303.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$297.93
Aprire:
$299.23
Volume 24 ore:
3.08M
Relative Volume:
0.89
Capitalizzazione di mercato:
$162.55B
Reddito:
$33.42B
Utile/perdita netta:
$4.09B
Rapporto P/E:
40.13
EPS:
7.55
Flusso di cassa netto:
$10.39B
1 W Prestazione:
+4.07%
1M Prestazione:
+10.26%
6M Prestazione:
-7.94%
1 anno Prestazione:
+6.90%
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMGN
Amgen Inc
|
303.01 | 162.55B | 33.42B | 4.09B | 10.39B | 7.55 |
![]()
LLY
Lilly Eli Co
|
873.68 | 830.35B | 45.04B | 10.59B | 414.30M | 11.71 |
![]()
NVO
Novo Nordisk Adr
|
88.08 | 390.99B | 42.09B | 14.65B | 10.11B | 3.2833 |
![]()
ABBV
Abbvie Inc
|
202.08 | 356.74B | 56.33B | 4.28B | 17.83B | 2.40 |
![]()
JNJ
Johnson Johnson
|
162.30 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
![]()
MRK
Merck Co Inc
|
89.50 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-10 | Ripresa | BofA Securities | Underperform |
2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
2024-11-14 | Iniziato | Citigroup | Neutral |
2024-10-17 | Iniziato | Bernstein | Outperform |
2024-10-14 | Downgrade | Truist | Buy → Hold |
2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-03-28 | Ripresa | Raymond James | Mkt Perform |
2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | Iniziato | Deutsche Bank | Hold |
2023-11-02 | Aggiornamento | Truist | Hold → Buy |
2023-10-20 | Ripresa | JP Morgan | Neutral |
2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
2023-10-11 | Ripresa | BofA Securities | Neutral |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2023-04-24 | Reiterato | Oppenheimer | Outperform |
2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2023-02-13 | Reiterato | Truist | Buy |
2022-11-18 | Iniziato | Credit Suisse | Underperform |
2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
2022-02-09 | Reiterato | Barclays | Equal Weight |
2022-02-09 | Reiterato | Jefferies | Buy |
2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
2022-02-09 | Reiterato | Oppenheimer | Outperform |
2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
2021-12-06 | Iniziato | Goldman | Buy |
2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-12-29 | Iniziato | Daiwa Securities | Buy |
2020-10-28 | Iniziato | UBS | Neutral |
2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-10-12 | Aggiornamento | Truist | Hold → Buy |
2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
2020-10-09 | Downgrade | Truist | Buy → Hold |
2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
2020-04-15 | Ripresa | Guggenheim | Neutral |
2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-02-27 | Iniziato | Barclays | Equal Weight |
2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
2019-12-24 | Iniziato | Raymond James | Mkt Perform |
2019-12-17 | Ripresa | Morgan Stanley | Overweight |
2019-11-12 | Iniziato | SunTrust | Buy |
2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
2019-10-17 | Ripresa | BofA/Merrill | Neutral |
2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Cordatus Wealth Management LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by JLB & Associates Inc. - MarketBeat
Mattern Capital Management LLC Sells 908 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nicholson Wealth Management Group LLC Acquires 1,855 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Compass Capital Corp MA ADV Acquires New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Advyzon Investment Management LLC Invests $232,000 in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's EVP David Reese sells $10.2 million in stock By Investing.com - Investing.com South Africa
Amgen EVP Esteban Santos sells $2.55 million in stock - Investing.com India
Amgen's EVP David Reese sells $10.2 million in stock - Investing.com
Amgen Executives Sell Shares Worth Over $12 Million - TradingView
Venturi Wealth Management LLC Boosts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - MSN
Derek Miller Takes Money Off The Table, Sells $593K In Amgen Stock - Benzinga
Amgen Inc. (NASDAQ:AMGN) is Hussman Strategic Advisors Inc.'s 9th Largest Position - MarketBeat
ING Groep NV Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cell Therapy Market Is Booming So Rapidly with Forecast by 2032 | Bristol Myers Squibb Company, Amgen, Johnson - EIN News
Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara - Seeking Alpha
Handelsbanken Fonder AB Sells 1,545 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
First Bank & Trust Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara -February 21, 2025 at 06:27 am EST - Marketscreener.com
There May Be Some Bright Spots In Amgen's (NASDAQ:AMGN) Earnings - Yahoo Finance
Ieq Capital LLC Reduces Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Americana Partners LLC Sells 888 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen SVP Derek Miller sells $593,933 in stock - Investing.com India
Truist Financial Corp Trims Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kentucky Retirement Systems Insurance Trust Fund Acquires 10,797 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Principal Financial Group Inc. Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bernstein cuts Amgen stock target to $350, maintains Outperform - Investing.com India
ICICI Prudential Asset Management Co Ltd Acquires 16,985 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bernstein Adjusts Amgen Price Target to $350 From $380, Maintains Outperform Rating - Marketscreener.com
Alberta Investment Management Corp Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Hudson Value Partners LLC - MarketBeat
Convergence Investment Partners LLC Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bryn Mawr Capital Management LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Private Advisor Group LLC Sells 5,009 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argus Cuts Price Target on Amgen to $330 From $360, Maintains Buy Rating -February 19, 2025 at 01:38 pm EST - Marketscreener.com
Looking Into Amgen's Recent Short Interest - Benzinga
Wilkinson Global Asset Management LLC Sells 6,077 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Northcape Wealth Management LLC Has $676,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
New York State Common Retirement Fund Grows Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
5,191 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Palacios Wealth Management LLC - MarketBeat
Chevy Chase Trust Holdings LLC Sells 6,084 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
New York State Teachers Retirement System Has $121.33 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Coho Partners Ltd. - MarketBeat
Amgen Inc. (AMGN): A Bull Case Theory - MSN
Empower Advisory Group LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Valley Wealth Managers Inc. Purchases 3,306 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Braun Stacey Associates Inc. Has $10.92 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Want Decades of Passive Income? Buy This ETF and Hold It Forever. - The Motley Fool
Mraz Amerine & Associates Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
D.A. Davidson & CO. Purchases 6,507 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Amgen Inc Azioni (AMGN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Santos Esteban | EVP, Operations |
Feb 19 '25 |
Sale |
292.84 |
8,711 |
2,550,903 |
71,546 |
REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Option Exercise |
156.35 |
8,711 |
1,361,965 |
70,858 |
REESE DAVID M | EVP & Chief Technology Officer |
Feb 21 '25 |
Sale |
304.44 |
25,225 |
7,679,524 |
36,922 |
REESE DAVID M | EVP & Chief Technology Officer |
Feb 19 '25 |
Sale |
293.22 |
8,711 |
2,554,224 |
62,147 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):